Congratulations to Alumnus Dr. Westbrook Weaver (Tempo Therapeutics) submitted their first medical device product for FDA clearance.

Tempo develops materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. We give power to regenerative medicine by controlling patient immunity to build synthetic tissue hybrids – from skin to bone to heart to brain.

True tissue engineering has long been the unifying goal in many clinical verticals, that together create a fast-growing market opportunity for which Tempo holds the transformative and enabling technology

SOURCE

  •  
  •  
  •  

UCLA Bioengineering

×